Endometrial carcinoma-derived stem-like cells (ECSCs) are commonly identified using specific cell surface markers, such as CD44-antigen (CD44) and Prominin-1 (CD133), as their expression is associated with tumorigenicity, invasiveness and metastasis [11,12,13]. The gene discussed is PROM1; the disease is endometrial carcinoma.